Detalhe da pesquisa
1.
Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.
Immunity
; 45(2): 280-91, 2016 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27496730
2.
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
N Engl J Med
; 367(9): 805-16, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931314
3.
NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
J Immunol
; 190(9): 4650-60, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23554313
4.
Donor activating KIR2DS1 in leukemia.
N Engl J Med
; 371(21): 2042, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409391
5.
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.
Blood
; 115(15): 3162-5, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124216
6.
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
Mult Scler
; 18(7): 951-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22185807
7.
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
J Immunol
; 183(4): 2837-50, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19635907
8.
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.
J Immunol
; 183(3): 1789-96, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19587011
9.
HLA alleles determine differences in human natural killer cell responsiveness and potency.
Proc Natl Acad Sci U S A
; 105(8): 3053-8, 2008 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18287063
10.
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
Clin Cancer Res
; 15(1): 299-306, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19118058
11.
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Clin Cancer Res
; 14(9): 2740-8, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18451240
12.
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
Br J Haematol
; 143(5): 641-53, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18950462
13.
Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.
Curr Opin Immunol
; 16(5): 634-43, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15342011
14.
Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.
Semin Hematol
; 42(2): 91-103, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15846575
15.
[Killer Ig-like receptor gene content diversity and haplotype analysis in Chinese Han population in Shanghai].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
; 20(5): 396-9, 2003 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-14556191
16.
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.
J Clin Invest
; 122(9): 3260-70, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863621
17.
Nomenclature for Factors of the HLA System, 2004.
Hum Immunol
; 66(5): 571-636, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15935895
18.
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
Hum Immunol
; 64(6): 648-54, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12770798
19.
Nomenclature for factors of the HLA system, 2002.
Hum Immunol
; 63(12): 1213-68, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12480266
20.
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Clin Cancer Res
; 15(13): 4467-74, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19531622